2026 NPPES data Pharmacotherapy Pharmacist NPI 1205873593 PHARM.D.
Verify on CMS →

JAIME ANAYA, PHARM.D.

Pharmacotherapy Pharmacist in EL PASO, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 262 beneficiaries · Pharmacotherapy Pharmacist avg: 397
Generic prescribing
60%
generic claims · 40% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: JAIME ANAYA, PHARM.D. is a Pharmacotherapy Pharmacist ([object Object]) practicing in EL PASO, Texas with a Medicare Part D prescribing footprint of 1K claims across 262 beneficiaries — 40% brand-name prescribing .

What stands out: JAIME ANAYA, PHARM.D. filed 1,183 Medicare Part D claims in 2023 across EL PASO, Texas. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

JAIME ANAYA, PHARM.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 06/02/2006

NPI 1205873593

Primary specialty

Pharmacotherapy Pharmacist

Mid-sized

5,925 US NPIs in this specialty

Medicare Part D claims

1,183 198% vs specialty avg

2023 prescription claims

Specialty avg: 397

Specialty distribution in Texas

How Pharmacotherapy Pharmacist compares to other specialties among Texas providers

Texas providers

Pharmacotherapy Pharmacist share within Texas

1. Pharmacotherapy Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacotherapy Pharmacist share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacotherapy Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacotherapy Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JAIME ANAYA, PHARM.D. is a Pharmacotherapy Pharmacist provider practicing in EL PASO, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARM.D.. NPI: 1205873593. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

JAIME ANAYA, PHARM.D. appears in the CMS NPPES registry as a Pharmacotherapy Pharmacist provider holding PHARM.D. credentials at 8061 ALAMEDA AVE, EL PASO, TX, 79915, with a listed phone of (915) 859-7545. NPI 1205873593 was issued on 06/02/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ANAYA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,183 prescription claims written by this provider, covering 262 Medicare beneficiaries and totaling roughly $595K in drug spend, split 40% brand-name and 60% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacotherapy Pharmacist is a mid-sized specialty nationwide, with 5,925 enrolled providers across 53 states and an average of 397 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

8061 ALAMEDA AVE
EL PASO, TX 79915

Provider Details

NPI 1205873593
Specialty Pharmacotherapy Pharmacist
Credentials PHARM.D.
Gender Male
NPI Issued 06/02/2006

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to JAIME ANAYA, PHARM.D.. To verify JAIME ANAYA, PHARM.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

JAIME ANAYA, PHARM.D. — brand share 40.0%
Specialty average (est.)

40% brand-name claims vs 60% generic, on 1,183 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,183
Total Claims
$595K
Total Drug Cost
262
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,393
Total Day Supply
71,063
Brand vs Generic
40% brand / 60% generic
Brand Drug Cost
$573K
Generic Drug Cost
$19K

Patient Demographics

Average Patient Age
70.3 years
Avg HCC Risk Score
1.32
Gender Split
60% female / 40% male
Age Distribution
<65: 38, 65-74: 157, 75-84: 52, 85+: 15

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Trulicity
Dulaglutide
107
Atorvastatin Calcium
89
Metformin Hcl
75
Ozempic
Semaglutide
67
Lisinopril
49
Levothyroxine Sodium
36
Hydrochlorothiazide
35
Losartan Potassium
32
Jardiance
Empagliflozin
29
Simvastatin
28

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacotherapy Pharmacist Overview

How JAIME ANAYA, PHARM.D. fits within the Pharmacotherapy Pharmacist landscape nationally.

5,925
Pharmacotherapy Pharmacist Providers in US
53
States with Pharmacotherapy Pharmacist
397
Avg Claims per Provider

JAIME ANAYA, PHARM.D.'s 1,183 claims are above the specialty average of 397.

Nearby Pharmacotherapy Pharmacist Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as ANAYA.

Compare Pharmacotherapy Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is JAIME ANAYA, PHARM.D.'s specialty?
JAIME ANAYA, PHARM.D. specializes in Pharmacotherapy Pharmacist and practices in EL PASO, Texas. Credentials: PHARM.D..
How much does JAIME ANAYA, PHARM.D. prescribe under Medicare Part D?
In 2023, JAIME ANAYA, PHARM.D. wrote 1,183 Medicare Part D claims totaling $595K in drug costs for 262 beneficiaries.
Where is JAIME ANAYA, PHARM.D. located?
JAIME ANAYA, PHARM.D. is located at 8061 ALAMEDA AVE, EL PASO, TX, 79915. Phone: (915) 859-7545.
What is JAIME ANAYA, PHARM.D.'s NPI number?
JAIME ANAYA, PHARM.D.'s National Provider Identifier (NPI) is 1205873593, issued on 06/02/2006.
Does JAIME ANAYA, PHARM.D. prescribe more brand-name or generic drugs?
JAIME ANAYA, PHARM.D.'s prescribing is 40% brand-name and 60% generic drugs by claim count, with $573K in brand drug costs.
How many Pharmacotherapy Pharmacist providers are there in the US?
There are 5,925 Pharmacotherapy Pharmacist providers across 53 states in the US. The average Pharmacotherapy Pharmacist provider writes 397 Medicare Part D claims per year.
What drugs does JAIME ANAYA, PHARM.D. prescribe most often?
Based on 2023 Medicare Part D data, JAIME ANAYA, PHARM.D.'s most frequently prescribed drugs include Trulicity, Atorvastatin Calcium, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JAIME ANAYA, PHARM.D. accept Medicare?
JAIME ANAYA, PHARM.D. appears in CMS Medicare data with 1,183 Part D claims and 262 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JAIME ANAYA, PHARM.D.'s credentials?
JAIME ANAYA, PHARM.D.'s NPI is 1205873593 with credentials PHARM.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology